The Indiana CTSI provides funding for special Pre-doctoral Training Awards in Translational Research.

In biomedical terminology translational research refers to what is popularly termed “bench to bedside”, the process by which research in the lab “translates” into patient treatment. Translation may involve applying discoveries made during research (in the lab, through animal studies, etc.) to the development of clinical trials and studies in humans, or carrying out research aimed at enhancing the adoption of best practices, or both.

These two types of translational research are usually described as consisting of either:

  1. T1 research -basic biomedical research, e.g. study disease at a molecular or cellular level, as it progresses to the development of new treatment options at the clinical level
  2. T2 research–¬†enhancing access to and the adoption of evidence-based strategies in clinical and community practice, institutionalizing programs, products, and services to improve health

Criteria for application include:

  • Candidates must have completed at least one year of a pre-doctoral training program but cannot have completed more than their third year (i.e., applicants must be in the second or third year of their pre-doctoral program when they apply).
  • Co-mentorship by faculty investigators from at least two different disciplines (preferably a clinician and a non-clinician scientist).
  • Research that is translational in nature and takes advantage of the synergism that comes from working at this basic/clinical interface.
  • U.S. citizen or permanent resident status.

Benefits include a stipend as well as health insurance and partial coverage of tuition and fees.

Trainees will be required to participate in a translational science course, attend a National CTSA meeting, and present their work at several Indiana CTSI pre-doctoral gatherings during the academic year.

Applications are due in December, and awards begin in July each year.

Note that pre-screening is required by November.